EP12.01. Single-Center Real-World Study of First Line Afatinib Treatment in Advanced EGFR-mutated Non-small Cell Lung Cancer in Vietnam - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Chau Pham
Meta Tag
Speaker Chau Pham
Topic Metastatic NSCLC: Targeted Therapy - EGFR/HER2
real-world study
epidermal growth factor receptor
EGFR-tyrosine kinase inhibitor
first-line treatment
non-small cell lung cancer
time to treatment failure
objective response rate
overall survival
Powered By